Educational resources

This section includes resources developed by Guidelines, including algorithms, medicines appraisal cards, supplements, and videos. Items may contain pharmaceutical promotional information.

Videos

Practical management of chronic obstructive pulmonary disease (COPD) in primary care
Commissioned by Boehringer Ingelheim Limited
Non-pharmacological interventions for chronic obstructive pulmonary disease (COPD)
Commissioned by Boehringer Ingelheim Limited
Optimal bronchodilation for management of chronic obstructive pulmonary disease (COPD)
Commissioned by Boehringer Ingelheim Limited
Management of common eye conditions: blepharitis
Funded by Allergan plc
Pulmonary embolism live webinar: Q&A session
Commissioned by Pfizer Ltd on behalf of the BMS – Pfizer Alliance
The management of patients with pulmonary embolism: a discussion
Commissioned by Pfizer Ltd on behalf of the BMS – Pfizer Alliance
Management of pulmonary embolism in secondary care in the acute phase of treatment
Commissioned by Pfizer Ltd on behalf of the BMS – Pfizer Alliance
The identification and treatment of pulmonary embolism in primary care
Commissioned by Pfizer Ltd on behalf of the BMS – Pfizer Alliance
Management of common eye conditions: conjunctivitis
Funded by Allergan plc
Management of common eye conditions: dry eye
Funded by Allergan plc
Management of common eye conditions: corneal and subtarsal foreign bodies
Funded by Allergan plc
Management of common eye conditions: chalazion (meibomian cyst)
Funded by Allergan plc
Management of common eye conditions: corneal abrasion
Funded by Allergan plc
Management of common eye conditions: subconjunctival haemorrhage
Funded by Allergan plc
Management of common eye conditions: episcleritis
Funded by Allergan plc
Management of common eye conditions: stye
Funded by Allergan plc
Management of common eye conditions: Glaucoma and the #knowyourdrops campaign
Funded by Allergan plc
Management of common eye conditions: introduction
Funded by Allergan plc

View more videos

Working party guidelines and algorithms

Consensus guideline on the holistic management of patients requiring anticoagulation

By Working party–Fay Antoniou Martins Merriman Patrickson Uprichard

Guideline for the managed introduction of biosimilar basal insulin

By Working party—Down Beba Brown Diggle Goel Milne

Medication management of patients with enteral feeding tubes

By Working party—Wright Griffith Merriman Smithard Smyth Welsh

Uncomplicated recurrent UTI guideline

By Working party—Rees Brocksom Harding Jacobson Rollinson

Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment

Commissioned by Bayer plc

Prescribing summary cards

DuoResp® Spiromax® (budesonide/formoterol)

Commissioned by Teva UK Limited

Dispensing summary cards

Saxenda® (liraglutide injection 3 mg)

Funded by Novo Nordisk Limited

Medicines appraisal cards

NICE Technology Appraisal 607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease

Commissioned by Bayer plc

The production of this Guidelines card has been commissioned by Bayer plc. Bayer plc has reviewed the card for technical accuracy and regulatory compliance and supplied the prescribing information.